TESTING OF A NEW COMPLEX COMPOSITION CIPROKLOZAL OF ASSOCIATIVE ECHINOSTOMATIDO-CRYPTOSPORIDIOSISINVASION IN YOUNG GROWTH DOMESTIC DUCKS

n this work, new data were obtained in the testing of a new composition Ciproklozal with an associative of echinostomatous-cryptosporidiosis invasion of young ducks. Experiments to determine the therapeutic efficacy of the new complex composition Ciproklozal with a mixed echinostomatous-cryptosporidiosis invasion of young ducks were carried out on of the group method. In the farm “Chegem”, on the basis of copro- and larvoscopy, young ducks infected with mycistinvasia and echoentomatisosis and cryptosporidiosis were selected and 3 groups of 20 heads in each were formed of them. Therapeutically effective dose of Ciproklozal of with a mixed of echinostomatous cryptosporidiosis invasion of young ducks is 0.20 g/kg of body weight, which has 100% extensive efficiency and intensive efficiency (EE and IE) in a single group administration. The eggs of ekhinostomidas and oocysts of cryptosporidium on day 7 after the group giving of the new composition Tsiproklozal were not found in the litter of the ducklings. In the experiments, the new complex composition Ciproklozal in a dose of 0.20 g/kg body weight, once mixed with compound feed, is environmentally safe, has no side effects and is recommended for the treatment and prevention of echinostomatidoses and cryptosporidiosis invasion in young of ducks.